Cargando…
Mesenchymal Stem Cell Therapy in Acute Liver Failure
Acute liver failure (ALF) is a severe liver disease syndrome with rapid deterioration and high mortality. Liver transplantation is the most effective treatment, but the lack of donor livers and the high cost of transplantation limit its broad application. In recent years, there has been no breakthro...
Autores principales: | Wang, Yong-Hong, Chen, En-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502502/ https://www.ncbi.nlm.nih.gov/pubmed/36843422 http://dx.doi.org/10.5009/gnl220417 |
Ejemplares similares
-
Progress in mesenchymal stem cell–based therapy for acute liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2018) -
Perspective of placenta derived mesenchymal stem cells in acute liver failure
por: Saleh, Mahshid, et al.
Publicado: (2020) -
Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015) -
Application of mesenchymal stem cell exosomes and their drug‐loading systems in acute liver failure
por: Zhang, Shuqin, et al.
Publicado: (2020) -
Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure
por: Ho, Cheng-Maw, et al.
Publicado: (2020)